Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
Clinical trial NCT01573702 · COMPLETED
Trial details
- NCT number
- NCT01573702
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-11
- Primary completion
- 2019-03-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.